NCT00701155View on ClinicalTrials.gov

Observational Study to Evaluate the Safety While Using Levemir®

CompletedOBSERVATIONAL

Enrollment

3,593

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of the actual clinical evaluation

Trial Locations (1)

0020

Giza

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY